Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes

Abstract

Influenza A virus nucleoprotein (NP) was integrated into immunostimulating complexes (ISCOMs) after attachment of bacterial lipopolysaccharide to the antigen. Oral immunization with these NP-ISCOMs protected mice fully against an otherwise lethal challenge infection with an unrelated influenza virus subtype without the appearance of severe clinical signs or extensive pathological lesions in the lungs. Mice immunized with analogous bovine serum albumine-incorporated ISCOMs all died. After oral immunization, high titers of NP-specific antibodies, particularly IgA, could be detected in the bronchoalveolar fluid and in the blood serum. No cytotoxic lymphocytes could be demonstrated in the spleens or the lungs of vaccinated mice, and no anti-NP antibody-dependent cytolysis of infected host cells was mediated by complement or in the form of an antibody-dependent cell cytotoxicity. However, a vigorous delayed-type hypersensitivity reaction was produced after probing vaccinated animals with purified NP. No comparable protective immunity or antibody response was induced by a strictly intragastric administration of NP-ISCOMs. It appears, therefore, that the general and local immune response in the lungs was primarily stimulated through contact of NP-ISCOMs with the mucous membrane of the oro-pharyngeal cavity and that cytotoxic effects did not play a major role for the establishment of the protective immunity. Partial protection against a lethal challenge was observed in chickens immunized with NP-ISCOMs in the drinking water.

This is a preview of subscription content, log in to check access.

References

  1. Andersson J, Melchers F, Galanos C, Lüderitz O (1973) The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule. J Exp Med 137:943–953

  2. Andrew ME, Coupar BEH (1988) Efficacy of influenza hemagglutinin and nucleoprotein as protective antigens against influenza virus infections in mice. Scand J Immunol 28:81–85

  3. Andrew ME, Coupar BEH, Boyle DB, Ada GL (1987) The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants. Scand J Immunol 25:21–28

  4. Becht H, Malole B (1975) Comparative evaluation of different fixation procedures and different coupling reagents for the demonstration of influenza virus-specific antibodies by the indirect hemagglutination test. Med Microbiol Immunol 162:43–53

  5. Bergström-Mollaoglu M, Lôvgren K, Akerblom L, Fossum C, Morein B (1992) Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical forms. Scand J Immunol 36:565–574

  6. Chen KS, Quinnan GV (1989) Efficacy of inactivated influenza vaccine delivered by oral administration. Curr Top Microbiol Immunol 146:101–106

  7. Endo A, Itamura S, Iinuma H, Funahashi S, Shida H, Koide F, Nerome K, Oya A (1991) Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein gene of influenza virus. J Gen Virol 72:699–703

  8. Hashimoto G, Wright PF, Karzon DT (1983) Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. J Infect Dis 148:785–794

  9. Jones PD, Tha Hla R, Morein B, Lôvgren K, Ada GL (1988) Cellular immune responses in the murine lung to immunization with influenza A virus glycoproteins in micells and immunostimulatory complex (Iscoms). Scand J Immunol 27:645–652

  10. Karupiah G, Ramsay AJ, Ramshaw IA, Blanden RV (1992) Recombinant vaccine vector-induced protection of athymic, nude mice from influenza A virus infection. Analysis of protective mechanism. Scand J Immunol 36:99–105

  11. Lawson CM, Bennink JR, Restifo NP, Yewdell JW, Murphy BR (1994) Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. J Virol 68:3505–3511

  12. Lin YL, Askonas BA (1981) Biological properties of an influenza A virus-specific killer T-cell clone. J Exp Med 154:225–234

  13. Lôvgren K (1988) The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes. Scand J Immunol 27:241–245

  14. Lukacher AE, Braciale VL, Braciale TJ (1984) In vivo effector function of influenza virus-specific cytotoxic T-lymphocyte clones is highly specific. J Exp Med 160:814–826

  15. Luo Y, Dorf ME (1993) Delayed-type hypersensitivity. In: Coligan JE, Kruisbeck AM, Margulies DH, Shevach EM, Strober W (eds) Current Protocols in Immunology. Greene and Wiley-Interscience, New York, pp 4.5.1–4.5.5

  16. Morein B (1988) The ISCOM antigen-presenting system. Nature 322:287–288

  17. Mowat AMcI, Donachie AM (1991) ISCOMS-a novel strategy for mucosal immunization? Immunol Today 12:383–385

  18. Mowat AMcI, Donachie AM, Reid G, Jarrett O (1991) Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology 72:317–322

  19. Pang GT, Clancy RL, O'Reilly SE, Cripps AW (1992) A novel paniculate influenza vaccine induces long-term and broad-based immunity in mice after oral immunization. J Virol 66:1162–1170

  20. Ramsay AJ, Ruby J, Ramshaw IA (1993) A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today 14:155–157

  21. Stitz L, Schmitz C, Binder D, Zinkernagel R, Paoletti E, Becht H (1990) Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection. J Gen Virol 71:1169–1179

  22. Takahashi H, Takeshita T, Morein B, Putney S, Germain RN, Berzofsky JA (1990) Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 344:873–875

  23. Taylor PM, Askonas BA (1986) Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology 58:417–420

  24. Tite JP, Hughes-Jenkins CM, O'Callaghan D, Dougan G, Russel SM, Gao X-M, Liew FY (1990a) Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection. Immunology 71:202–207

  25. Tite JP, Gao X-M, Hughes-Jenkins CM, Lipscombe M, O'Callaghan D, Dougan G, Liew FY (1990b) Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. Immunology 70:540–546

  26. Townsend A, Bodman H (1989) Antigen recognition by class I-restricted T-lymphocytes. Annu Rev Immunol 7:601–624

  27. Villacres-Eriksson M, Bergström-Mollaoglu M, Kåberg H, Morein B (1992) Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus Iscoms. Scand J Immunol 36:421–426

  28. Virelizier JL, Allison AC, Oxford JS, Schild GC (1977) Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells. Nature 266:52–54

  29. Walker RI (1994) New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 12:387–400

  30. Webster RD, Kawaoka Y, Taylor J, Weinberg R, Paoletti E (1991) Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9:303–308

  31. Weiß HP, Stitz L, Becht H (1990) Immunogenic properties of ISCOM prepared with influenza virus nucleoprotein. Arch Virol 114:109–120

  32. Wraith DC (1987) The recognition of influenza A virus-infected cells by cytotoxic T-lymphocytes. Immunol Today 8:239–246

  33. Wraith DC, Vessey AE, Askonas BA (1987) Purified influenza virus nucleoprotein protects mice from lethal infection. J Gen Virol 68:433–440

  34. Yewdell JW, Hackett CJ (1989) Specificity and function of T lymphocytes induced by influenza A viruses. In: Krug RM (ed) The influenza viruses. Plenum Press, New York, pp 361–429

Download references

Author information

Correspondence to K. Scheepers.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Scheepers, K., Becht, H. Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes. Med Microbiol Immunol 183, 265–278 (1994). https://doi.org/10.1007/BF00198460

Download citation

Keywords

  • Influenza
  • Influenza Virus
  • Challenge Infection
  • Oral Immunization
  • Bronchoalveolar Fluid